Journey Through Cholesteryl Ester Transfer Protein Inhibition From Bench to Bedside

被引：12
作者：
Karalis, Ioannis [1 ]
Rensen, Patrick C. N. [2 ,3 ]
Jukema, J. Wouter [1 ,3 ,4 ,5 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands
[4] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands
[5] Interuniv Cardiol Inst ICIN, Utrecht, Netherlands
来源：
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2013年 / 6卷 / 03期
关键词：
atherosclerosis; high-density lipoprotein; lipids and lipoprotein metabolism; HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; INCREASES HDL-CHOLESTEROL; RANDOMIZED CLINICAL-TRIAL; LIPID-LEVEL MANAGEMENT; MYOCARDIAL-INFARCTION; VASCULAR-DISEASE; CETP INHIBITION; BLOOD-PRESSURE; GENE MUTATION;
D O I：
10.1161/CIRCOUTCOMES.111.000014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：360 / 366
页数：7
相关论文
共 67 条
  • [1] Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197
  • [2] Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
    Agerholm-Larsen, B
    Nordestgaard, BG
    Steffensen, R
    Jensen, G
    Tybjærg-Hansen, A
    [J]. CIRCULATION, 2000, 101 (16) : 1907 - 1912
  • [3] Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease -: The Copenhagen City Heart Study
    Andersen, RV
    Wittrup, HH
    Tybærg-Hansen, A
    Steffensen, R
    Schnohr, P
    Nordestgaard, BG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) : 1972 - 1982
  • [4] Hepatic lipase gene therapy in hepatic lipase-deficient mice - Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium
    ApplebaumBowden, D
    Kobayashi, J
    Kashyap, VS
    Brown, DR
    Berard, A
    Meyn, S
    Parrott, C
    Maeda, N
    Shamburek, R
    Brewer, HB
    SantamarinaFojo, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) : 799 - 805
  • [5] RELATION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDES TO INCIDENCE OF ATHEROSCLEROTIC CORONARY-ARTERY DISEASE (THE PROCAM EXPERIENCE)
    ASSMANN, G
    SCHULTE, H
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (07) : 733 - 737
  • [6] Lessons Learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
    Barter, Philip
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (10A) : 10E - 15E
  • [7] Effects of torcetrapib in patients at high risk for coronary events
    Barter, Philip J.
    Caulfield, Mark
    Eriksson, Mats
    Grundy, Scott M.
    Kastelein, John J. P.
    Komajda, Michel
    Lopez-Sendon, Jose
    Mosca, Lori
    Tardif, Jean-Claude
    Waters, David D.
    Shear, Charles L.
    Revkin, James H.
    Buhr, Kevin A.
    Fisher, Marian R.
    Tall, Alan R.
    Brewer, Bryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
  • [8] Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
    Barter, Philip J.
    Rye, Kerry-Anne
    [J]. JOURNAL OF LIPID RESEARCH, 2012, 53 (09) : 1755 - 1766
  • [9] Antiinflammatory properties of HDL
    Barter, PJ
    Nicholls, S
    Rye, KA
    Anantharamaiah, GM
    Navab, M
    Fogelman, AM
    [J]. CIRCULATION RESEARCH, 2004, 95 (08) : 764 - 772
  • [10] Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
    Bots, Michiel L.
    Visseren, Frank L.
    Evans, Gregory W.
    Riley, Ward A.
    Revkin, James H.
    Tegeler, Charles H.
    Shear, Charles L.
    Duggan, William T.
    Vicari, Ralph M.
    Grobbee, Diederick E.
    Kastelein, John J.
    [J]. LANCET, 2007, 370 (9582) : 153 - 160
1234567